CASP3 and Zika virus infectious disease: 6-AZA treatment significantly reduced caspase 3/7 activity at 5 and 10 μM concentrations (Figure 4C), which correlated with the significant decrease in ZIKV infection (IC50 of 5 μM) (Figure 4D).